Article
16 May 2018
A Cautiously Optimistic Diagnosis For Patent Eligibility
AUTHORS CONTENT
Article
07 Nov 2017
Fenwick's Top Articles On Privacy, Patent Venue, Index Rules, SCOTUS And More
Article
29 Sep 2017
Federal Circuit Provides Much Needed Patent Venue Guidance Post TC Heartland
Article
25 Jul 2016
Federal Circuit: A Biosimilar Applicant Must Provide Notice Of Intent To Market A Biosimilar Product, No Exceptions
Article
20 Jul 2016
Litigation Alert: No Exception To Statutory Requirement That A Biosimilar Applicant Provide Notice Of Intent To Market Its Product
Article
01 Jul 2016
Litigation Alert: Supreme Court Leaves Intact PTAB Authority To Institute And Regulate Inter Partes Review Proceedings
Article
30 Jun 2016
Biosimilars: Supreme Court Calls For Solicitor General's Views In Amgen V. Sandoz
Article
14 Mar 2016
Lingering In Lexmark's Wake, Uncertainty About The Limits Of Patent Exhaustion
Article
05 Nov 2015
Federal Circuit's Ariosa Decision, Good Chance For Rehearing En Banc
Article
01 Oct 2015
U.S. Supreme Court Upholds Ban On Post-Patent Expiration Royalties
Article
21 Aug 2015
Federal Circuit Expands Liability For Divided Patent Infringement
Article
12 Aug 2015
Riddle Me This: The Federal Circuit Provides A Measure Of Clarity To The Enigmatic Biosimilar Approval Pathway
Article
25 Jun 2015
Even Spider-Man Can't Defeat Ban On Post-Patent Expiration Royalties
Article
09 Jun 2015
A Good-Faith Belief Of Patent Invalidity Is Not A Defense To Inducement of Infringement
Article
19 Jun 2013
Supreme Court Rules On "Reverse Payment" Settlements In Federal Trade Commission v. Actavis, Inc.
Article
18 Jun 2013
Supreme Court Rules On "Reverse Payment" Settlements In Federal Trade Commission v. Actavis, Inc.
Article
10 Apr 2013
Murky Waters: Post-Approval Regulatory Activities And The § 271(e)(1) Safe Harbor
Article
05 Apr 2013
U.S. Supreme Court To Weigh In On Reverse Payment Deals
Article
09 May 2012
Supreme Court Allows Generic Manufacturers To Challenge Overbroad Use Codes